Elevation Oncology (ELEV) Earnings Date, Estimates & Call Transcripts $0.36 0.00 (0.00%) As of 07/23/2025 Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Elevation Oncology Earnings Summary Elevation Oncology released Q1 2025 earnings on May 15, 2025, reporting an EPS of -$0.24, which missed the consensus estimate of -$0.20 by $0.04. With a trailing EPS of -$0.82, Elevation Oncology's earnings are expected to decrease next year, from ($0.84) to ($0.89) per share. Latest Q1 Earnings DateMay. 15EstimatedConsensus EPS (May. 15) -$0.20 Actual EPS (May. 15) -$0.24 Missed By -$0.04 Q1 2025 Earnings ResourcesQ1 2025 Earnings Report Quarterly Report (10-Q) Press Release (8-K)Powered by Get Elevation Oncology Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Elevation Oncology and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataELEV Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Elevation Oncology Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20253-$0.27-$0.21-$0.24Q2 20254-$0.36-$0.21-$0.28Q3 20254-$0.23-$0.21-$0.22Q4 20254-$0.24-$0.17-$0.21 FY 2025 15 -$1.10 -$0.80 -$0.94 Q1 20261-$0.18-$0.18-$0.18Q2 20261-$0.19-$0.19-$0.19Q3 20261-$0.11-$0.11-$0.11Q4 20261-$0.13-$0.13-$0.13 Elevation Oncology Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails5/15/2025Q1 2025-$0.20-$0.24 -$0.04-$0.24--3/6/2025Q4 2024-$0.22-$0.18+$0.04-$0.18--11/6/2024--$0.20-$0.22 -$0.02-$0.22--8/6/2024--$0.23-$0.18+$0.05-$0.18--5/2/2024Q1 2024-$0.21-$0.23 -$0.02-$0.23--3/6/2024Q4 2023-$0.21-$0.19+$0.02-$0.19--11/2/2023Q3 2023-$0.34-$0.25+$0.09-$0.25-- Elevation Oncology Earnings - Frequently Asked Questions When did Elevation Oncology announce their last quarterly earnings? Elevation Oncology (NASDAQ:ELEV) last announced its quarterly earning data on Thursday, May 15, 2025. Learn more on ELEV's earnings history. Did Elevation Oncology beat their earnings estimates last quarter? In the previous quarter, Elevation Oncology (NASDAQ:ELEV) missed the analysts' consensus estimate of ($0.20) by $0.04 with a reported earnings per share (EPS) of ($0.24). Learn more on analysts' earnings estimate vs. ELEV's actual earnings. How much profit does Elevation Oncology generate each year? Elevation Oncology (NASDAQ:ELEV) has a recorded net income of -$44.49 million. ELEV has generated -$0.82 earnings per share over the last four quarters. What is Elevation Oncology's EPS forecast for next year? Elevation Oncology's earnings are expected to decrease from ($0.84) per share to ($0.89) per share in the next year. More Earnings Resources from MarketBeat Related Companies AVTX Earnings VXRT Earnings EXOZ Earnings MGX Earnings ELUT Earnings BYSI Earnings EPIX Earnings ANRO Earnings ABOS Earnings IGMS Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Dutch Bros Just Flipped the Script With a Massive Earnings BeatIs Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity?Constellation Energy’s Earnings Beat Signals a New EraRealty Income Rallies Post-Earnings Miss—Here’s What Drove ItDon't Mix the Signal for Noise in Super Micro Computer's EarningsWhy Monolithic Power's Earnings and Guidance Ignited a RallyRivian Takes Earnings Hit—R2 Could Be the Stock's 2026 Lifeline This page (NASDAQ:ELEV) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredGold Hit $3,500. Here’s What’s Next…Gold just smashed through $3,500—and some experts believe that’s only the beginning. With big banks like Goldm...Reagan Gold Group | SponsoredShocked one of my clients with thisTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elevation Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Elevation Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.